Living With Primary Ciliary Dyskinesia (Living With PCD)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Bern

About this trial

Living with PCD (formerly COVID-PCD) is a participatory research project that aims to answer emerging questions about primary ciliary dyskinesia (PCD) in order to improve the health and quality of life of people with PCD. Persons with confirmed or suspected PCD from anywhere in the world can participate. The study is advertised through patient support groups and participants register online after they read detailed information about the study. Participants receive a detailed questionnaire when they start the study and a follow-up questionnaire (planned once per year). Occasionally, participants receive extra questionnaires focused on special topics. The study is hosted at the University of Bern and recruitment started on May 30th, 2020.

Eligibility criteria

Qualifiers

People of any age with reported suspected or confirmed Primary Ciliary Dyskinesia who gave consent to participate in the study

Disqualifiers

People who report not to have suspected or confirmed Primary Ciliary Dyskinesia

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of Bern

Lead sponsor

Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesie

Collaborator

Verein Kartagener Syndrom und PCD

Collaborator

PCD Support UK

Collaborator

PCD Foundation

Collaborator

PCD Australia

Collaborator

European Lung Foundation

Collaborator

University of Southampton

Collaborator

Universität Luzern

Collaborator

Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kargagener APS

Collaborator

Asociación Nacional de Pacientes con Discinesia Ciliar Primaria

Collaborator

Association Dyskinésie Ciliaire Primitive ADCP

Collaborator